Dupilumab treatment is not associated with an increased overall risk of infections in patients aged 6 months to 5 years with moderate-to-severe atopic dermatitis

被引:0
|
作者
Siegfried, Elaine C. [1 ,2 ]
Cork, Michael J. [3 ]
Arkwright, Peter D. [4 ]
Wollenberg, Andreas [5 ,6 ]
Eichenfield, Lawrence F. [7 ,8 ]
Ramien, Michele [9 ,10 ]
Khokhar, Faisal A. [11 ]
Chen, Zhen [11 ]
Zhang, Annie [12 ]
Cyr, Sonya L. [11 ]
机构
[1] St Louis Univ, St Louis, MO USA
[2] Cardinal Glennon Childrens Hosp, St Louis, MO USA
[3] Univ Sheffield, Sheffield Dermatol Res, Sheffield, England
[4] Univ Manchester, Manchester, England
[5] Ludwig Maximilians Univ Munchen, Munich, Germany
[6] UZ Brussel, VUB, Brussels, Belgium
[7] Univ Calif San Diego, San Diego, CA USA
[8] Rady Childrens Hosp, San Diego, CA USA
[9] Alberta Childrens Prov Gen Hosp, Calgary, AB, Canada
[10] Univ Calgary, Calgary, AB, Canada
[11] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[12] Sanofi, Cambridge, MA USA
关键词
atopic dermatitis; children; infections; safety; dupilumab;
D O I
10.1093/bjd/ljac140.031
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
337
引用
收藏
页数:2
相关论文
共 50 条
  • [1] LONG-TERM DUPILUMAB TREATMENT IS NOT ASSOCIATED WITH AN INCREASED OVERALL RISK OF INFECTIONS IN PATIENTS AGED 6 MONTHS TO 5 YEARS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS IN AN OPENLABEL EXTENSION STUDY
    Paller, Amy S.
    Ramien, Michele
    Cork, Michael J.
    Simpson, Eric L.
    Lee, Lara Wine
    Eichenfield, Lawrence F.
    Coleman, Anna
    Gherardi, Guy
    Tian, Tingting
    Zhang, Annie
    Cyr, Sonya L.
    ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 54 - 54
  • [2] Dupilumab Treatment is Not AssociatedWith an Increased Overall Risk of Infections in Patients Aged 6 Months to 5 yearsWithModerate-to-Severe Atopic Dermatitis
    Pinter, Andreas
    Cork, Michael J.
    Siegfried, Elaine C.
    Arkwright, Peter D.
    Wollenberg, Andreas
    Eichenfield, Lawrence F.
    Ramien, Michele
    Khokhar, Faisal A.
    Chen, Zhen
    Zhang, Annie
    Cyr, Sonya L.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 100 - 101
  • [3] EFFICACY AND SAFETY OF DUPILUMAB IN CHILDREN AGED 6 MONTHS TO 5 YEARS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Worrell, Richard
    Paller, Amy S.
    Siegfried, Elaine C.
    Simpson, Eric L.
    Wollenberg, Andreas
    Gonzalez, Mercedes E.
    Sidbury, Robert
    Lockshin, Benjamin
    Dubost-Brama, Ariane
    Bansal, Ashish
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 31 - 32
  • [4] DUPILUMAB REDUCES ITCH IN CHILDREN WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS AGED 6 MONTHS TO 5 YEARS
    Paller, A. S.
    Siegfried, E. C.
    Yosipovitch, G.
    Kwatra, S. G.
    Praestgaard, A.
    Prescilla, R.
    Wang, J.
    VALUE IN HEALTH, 2023, 26 (06) : S57 - S58
  • [5] Dupilumab Reduces Itch in Children with Moderate-to-Severe Atopic Dermatitis Aged 6 Months to 5 Years
    Paller, Amy S.
    Siegfried, Elaine C.
    Yosipovitch, Gil
    Kwatra, Shawn G.
    Praestgaard, Amy
    Wang, Zhixiao
    Prescilla, Randy
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB151 - AB151
  • [6] Long-term dupilumab treatment is not associated with an increased overall risk of infections in adults with moderate-to-severe atopic dermatitis
    Beck, Lisa A.
    Simpson, Eric L.
    Thaci, Diamant
    de Bruin-Weller, Marjolein
    Deleuran, Mette
    Kataoka, Yoko
    Friedman, Adam J.
    Khokhar, Faisal A.
    Coleman, Anna
    Gherardi, Guy
    Chen, Zhen
    Avetisova, Elena
    Zhang, Annie
    Nguyen, Tien, V
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : 71 - 72
  • [7] Dupilumab Reduces Inflammatory Biomarkers in Patients Aged 6 Months to 18 Years With Moderate-to-Severe or Severe Atopic Dermatitis
    Beck, Lisa
    Muraro, Antonella
    Boguniewicz, Mark
    Chen, Zhen
    Levit, Noah
    Marco, Ainara Rodriguez
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB152 - AB152
  • [8] Dupilumab Treatment Improves Sleep Quality in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis and Their Caregivers
    Paller, Amy S.
    Simpson, Eric L.
    Siegfried, Elaine C.
    Cork, Michael J.
    Wollenberg, Andreas
    Arkwright, Peter D.
    Praestgaard, Amy
    Prescilla, Randy
    Wang, Zhixiao
    Marco, Ainara Rodriguez
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB40 - AB40
  • [9] 411 Long term laboratory safety of dupilumab in patients aged 6 months to 5 years with moderate-to-severe atopic dermatitis
    Siegfried, Elaine
    Cork, Michael J.
    Lockshin, Benjamin
    Boguniewicz, Mark
    Uppal, Sumeet
    Khokhar, Faisal A.
    Bansal, Ashish
    Sierka, Debra
    Cyr, Sonya
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [10] Long Term Hematologic Laboratory Safety of Dupilumab in Patients Aged 6 Months to 5 Years With Moderate-to-Severe Atopic Dermatitis
    Siegfried, Elaine
    Cork, Michael J.
    Lockshin, Benjamin
    Boguniewicz, Mark
    Uppal, Sumeet
    Vass, Maria
    Khokhar, Faisal A.
    Bansal, Ashish
    Sierka, Debra
    Cyr, Sonya
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB62 - AB62